BioCardia

About:

BioCardia is a clinical-stage regenerative medicine company.

Website: http://www.biocardia.com/

Description:

BioCardia is a clinical-stage regenerative medicine company. We are a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. BioCardia is developing proprietary comprehensive biotherapeutic solutions for cardiovascular disease in its CardiAMP™ and CardiALLO™ therapies. Clinical results supporting both therapeutic programs are compelling and build upon the most rigorous data in the field to date with intramyocardial delivery of marrow-derived cells.

Total Funding Amount:

$48.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Carlos, California, United States

Founded Date:

1999-01-01

Founders:

Peter A Altman

Number of Employees:

11-50

Last Funding Date:

2024-08-30

IPO Status:

Public

Industries:

© 2025 bioDAO.ai